The Council of Canadians is pleased that the Canada-EU trade deal, the Comprehensive Economic and Trade Agreement (CETA), has seen the light of day after German television show Tagesschau provided the full text online this afternoon.
"Throughout the process, this agreement and its devastating impacts have been kept locked away from legislators and the public, shielded from a democratic process. Finally, it comes to light, probably because people in Germany are fed up with the secrecy and fed up with being taken hostage by companies," says Maude Barlow, Council of Canadians national chairperson.
The Harper government has celebrated the completion of the agreement this week, setting a signing date of September 26. CETA's investor-state dispute settlement provisions have been on the radar in Germany, where there is opposition to them. They would allow corporations to sue countries for lost profit. The Vattenfall decision, where a company sued Germany for pulling out of the nuclear industry, is fresh in Germany's mind after the Fukushima nuclear accident.
"Obviously, the Harper government is tone deaf when it comes to relations with Germany and the growing opposition to CETA. We are committed to working with the opposition in Europe to kill this 'corporate bill of rights,'" remarked Barlow.
- This text (and earlier versions of it) should have been made public to give the public the appropriate amount of time to read it, discern its contents and comment on it fully. The whole CETA negotiation process has been undemocratic, and has failed in terms of transparency.
- The 25-page investor-state section appears to be a standard investor-state dispute settlement: a three-person panel that would make decisions rather than the mature court systems. This probably will not placate Germany.
- The 30-page procurement section appears to give no consideration to the numerousCanadian municipalities that requested to be exempted from its provisions.
- The EU language was adopted on resolution of pharmaceutical patent disputes. This will open the flood gates to pharmaceutical companies' law suits. This will lengthen patent lengths and delay generics coming to market. In the end, this could severely increase public health care costs by $900 million to $1.7 billion.
Thank you for reading this story…
More people are reading rabble.ca than ever and unlike many news organizations, we have never put up a paywall – at rabble we’ve always believed in making our reporting and analysis free to all, while striving to make it sustainable as well. Media isn’t free to produce. rabble’s total budget is likely less than what big corporate media spend on photocopying (we kid you not!) and we do not have any major foundation, sponsor or angel investor. Our main supporters are people and organizations -- like you. This is why we need your help. You are what keep us sustainable.
rabble.ca has staked its existence on you. We live or die on community support -- your support! We get hundreds of thousands of visitors and we believe in them. We believe in you. We believe people will put in what they can for the greater good. We call that sustainable.
So what is the easy answer for us? Depend on a community of visitors who care passionately about media that amplifies the voices of people struggling for change and justice. It really is that simple. When the people who visit rabble care enough to contribute a bit then it works for everyone.
And so we’re asking you if you could make a donation, right now, to help us carry forward on our mission. Make a donation today.